324 related articles for article (PubMed ID: 21169466)
1. Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine.
Agusti A; Sobradillo P; Celli B
Am J Respir Crit Care Med; 2011 May; 183(9):1129-37. PubMed ID: 21169466
[TBL] [Abstract][Full Text] [Related]
2. Translational bioinformatics and systems biology approaches for personalized medicine.
Yan Q
Methods Mol Biol; 2010; 662():167-78. PubMed ID: 20824471
[TBL] [Abstract][Full Text] [Related]
3. Moving from the Oslerian paradigm to the post-genomic era: are asthma and COPD outdated terms?
Vanfleteren LE; Kocks JW; Stone IS; Breyer-Kohansal R; Greulich T; Lacedonia D; Buhl R; Fabbri LM; Pavord ID; Barnes N; Wouters EF; Agusti A
Thorax; 2014 Jan; 69(1):72-9. PubMed ID: 23794191
[TBL] [Abstract][Full Text] [Related]
4. P4 medicine: the future around the corner.
Sobradillo P; Pozo F; Agustí A
Arch Bronconeumol; 2011 Jan; 47(1):35-40. PubMed ID: 21190770
[TBL] [Abstract][Full Text] [Related]
5. The COPD control panel: towards personalised medicine in COPD.
Agusti A; MacNee W
Thorax; 2013 Jul; 68(7):687-90. PubMed ID: 23117977
[TBL] [Abstract][Full Text] [Related]
6. Editorial: Systems biology and personalized medicine - the future is now.
Auffray C; Hood L
Biotechnol J; 2012 Aug; 7(8):938-9. PubMed ID: 22887882
[TBL] [Abstract][Full Text] [Related]
7. [Toward personalized and integrated treatment of patients with COPD].
Ancochea J; Gómez García T; de Miguel Díez J
Arch Bronconeumol; 2010 Dec; 46 Suppl 10():14-8. PubMed ID: 21316551
[TBL] [Abstract][Full Text] [Related]
8. Quantifying your body: a how-to guide from a systems biology perspective.
Smarr L
Biotechnol J; 2012 Aug; 7(8):980-91. PubMed ID: 22887886
[TBL] [Abstract][Full Text] [Related]
9. [PERSONALIZED MEDICINE: CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATMENT].
Corhay JL
Rev Med Liege; 2015; 70(5-6):310-5. PubMed ID: 26285458
[TBL] [Abstract][Full Text] [Related]
10. From -omics to personalized medicine in nephrology: integration is the key.
Pesce F; Pathan S; Schena FP
Nephrol Dial Transplant; 2013 Jan; 28(1):24-8. PubMed ID: 23229923
[TBL] [Abstract][Full Text] [Related]
11. Systems medicine and metabolic modelling.
Mardinoglu A; Nielsen J
J Intern Med; 2012 Feb; 271(2):142-54. PubMed ID: 22142312
[TBL] [Abstract][Full Text] [Related]
12. [Phenotypic heterogeneity of chronic obstructive pulmonary disease].
Garcia-Aymerich J; Agustí A; Barberà JA; Belda J; Farrero E; Ferrer A; Ferrer J; Gáldiz JB; Gea J; Gómez FP; Monsó E; Morera J; Roca J; Sauleda J; Antó JM;
Arch Bronconeumol; 2009 Mar; 45(3):129-38. PubMed ID: 19246148
[TBL] [Abstract][Full Text] [Related]
13. What does endotyping mean for treatment in chronic obstructive pulmonary disease?
Agustí A; Celli B; Faner R
Lancet; 2017 Sep; 390(10098):980-987. PubMed ID: 28872030
[TBL] [Abstract][Full Text] [Related]
14. [Complexity in chronic obstructive pulmonary disease. Individualized treatment, new approaches, phenotypes and comorbidities].
Martín-Escudero JC
Rev Clin Esp; 2011 Mar; 211 Suppl 2():13-21. PubMed ID: 21596169
[TBL] [Abstract][Full Text] [Related]
15. From pharmacogenomics and systems biology to personalized care: a framework of systems and dynamical medicine.
Yan Q
Methods Mol Biol; 2014; 1175():3-17. PubMed ID: 25150863
[TBL] [Abstract][Full Text] [Related]
16. Systems medicine: helping us understand the complexity of disease.
Vandamme D; Fitzmaurice W; Kholodenko B; Kolch W
QJM; 2013 Oct; 106(10):891-5. PubMed ID: 23904523
[TBL] [Abstract][Full Text] [Related]
17. Personalizing and targeting therapy for COPD: the role of molecular and clinical biomarkers.
Goh F; Shaw JG; Savarimuthu Francis SM; Vaughan A; Morrison L; Relan V; Marshall HM; Dent AG; O'Hare PE; Hsiao A; Bowman RV; Fong KM; Yang IA
Expert Rev Respir Med; 2013 Dec; 7(6):593-605. PubMed ID: 24160750
[TBL] [Abstract][Full Text] [Related]
18. Moving towards patient-centered medicine for COPD management: multidimensional approaches versus phenotype-based medicine--a critical view.
Lopez-Campos JL; Bustamante V; Muñoz X; Barreiro E
COPD; 2014 Sep; 11(5):591-602. PubMed ID: 24914771
[TBL] [Abstract][Full Text] [Related]
19. Phenotypes and disease characterization in chronic obstructive pulmonary disease. Toward the extinction of phenotypes?
Agustí A
Ann Am Thorac Soc; 2013 Dec; 10 Suppl():S125-30. PubMed ID: 24313762
[TBL] [Abstract][Full Text] [Related]
20. Translational implications of inflammatory biomarkers and cytokine networks in psychoneuroimmunology.
Yan Q
Methods Mol Biol; 2012; 934():105-20. PubMed ID: 22933143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
